期刊文献+

血清前列腺特异性抗原预测中国男性前列腺增生患者前列腺体积的准确性研究 被引量:6

Accuracy of serum tPSA, fPSA in predicting prostate volume of Chinese LUTS/BPO-a single center study
原文传递
导出
摘要 目的通过比较血清总前列腺特异性抗原(t PSA)、游离前列腺特异性抗原(f PSA)与年龄预测前列腺体积(PV)大小的准确性,寻找预测PV简便易行、较准确的预测因子。方法收集2005年1月至2014年12月因下尿路症状到我院诊治下尿路症状/良性前列腺梗阻(LUTS/BPO)患者的年龄、PV及PSA检测值;采用SPSS 13.0软件处理数据,用皮尔森线性相关关系描述年龄、血清t PSA及血清f PSA与PV的相关性,并采用卡方检验及受试者特征曲线(ROC)分析比较血清t PSA、血清f PSA预测PV的准确性。结果入选6 308例男性,皮尔森线性相关分析显示年龄-PV、t PSA-PV和f PSA-PV的相关系数分别是0.197、0.434、和0.446,其P值均<0.05,具有相关性;在t PSA为0~4μg/L时,t PSA和f PSA预测PV在(30~50)ml、(50~70)ml和PV>70 ml组的AUC-ROC分别为(0.617、0.732、0.761)和(0.625、0.738、0.767);在t PSA为0~4μg/L时,t PSA和f PSA预测PV在(30~50)ml、(50~70)ml和PV>70 ml组的最佳临界值分别为t PSA(1.3μg/L、1.6μg/L、2.0μg/L)和f PSA(0.3μg/L、0.4μg/L、0.5μg/L)。结论中国LUTS/BPO男性血清f PSA与PV正相关程度最高,血清t PSA与f PSA均可作为独立预测因子预测中国LUTS/BPO男性的PV,可作为临床上预测PV简便易行的指标,其中f PSA预测的准确性更高。 Objective To compare the accuracy of serum total prostate-specifc antigen (tPSA), free PSA (fPSA) and age in predicting prostate volume (PV), aiming to identify the simple and accurate biomarkers for predicting PV. Methods Age, PV, and PSA values of patients diagnosed with lower urinary tract symptoms/benign prostatic obstruction (LUTS/BPO) admitted to our hospital from January 2005 to December 2014 were collected. The data was processed using SPSS 13.0 statistical software. Pearson's linear correlation was utilized to describe the correlation between age, serum tPSA, serum fPSA and PV. Chi-square test and the receiver characteristic curve (ROC) were used to analyze and compare the accuracy of serum tPSA and fPSA in predicting PV. Results A total of 6308 male patients were enrolled. Pearson's linear correlation analysis demonstrated that the correlation coeffcients of age-PV, tPSA-PV and fPSA-PV were 0.197, 0.434, and 0.446, respectively (all P〈0.05). When tPSA was 0-4 μg/L, the AUC-ROC of tPSA and fPSA in predicting PV in the (30-50), (50-70) and 〉70 ml groups were (0.617, 0.732, 0.761) and (0.625, 0.738, 0.767), respectively. When tPSA was 0-4 μg/L, the optimal cut-off values of tPSA and fPSA in predicting PV in the (30-50), (50-70), and PV〉 70 ml groups were (1.3 μg/L, 1.6 μg/L, 2.0 μg/L)and (0.3 μg/L, 0.4 μg/L, 0.5 μg/L), respectively. Conclusions The serum fPSA possesses the highest positive correlation with PV in the male LUTS/BPO patients in China. Serum tPSA and fPSA can be considered as independent biomarkers to predict the PV in this population, which can be used as simple and convenient predictors for PV in clinical practice. fPSA yields higher prediction accuracy compared with tPSA.
作者 杨文俊 胡成 刘思容 汤平 欧汝彪 韦兴华 谢克基 Yang Wenjun;Hu Cheng;Liu Sirong;Tang Ping;Ou Rubiao;Wei Xinghua;Xie Keji(Department of Urology,Guangzhou First People's Hospital,Guangzhou 510180,China;Department of Urology,the Third Affliated Hospital,Sun Yat-Sen University,Guangzhou,510630,China)
出处 《中华腔镜泌尿外科杂志(电子版)》 2018年第3期154-158,共5页 Chinese Journal of Endourology(Electronic Edition)
基金 广州市医药卫生科技项目(20172A010002)
关键词 前列腺特异性抗原 下尿路症状 前列腺增生 前列腺体积 Prostate specific antigen Lower urinary tract symptoms Benign prostatic hyperplasia Prostate volume
  • 相关文献

参考文献2

二级参考文献22

  • 1王志平,陈一戎,刘国栋.花粉提取物对前列腺增生细胞作用的研究[J].中华泌尿外科杂志,1995,16(12):732-733. 被引量:15
  • 2Emberton M, Andriole GL, de la Rosette J, Djavan B, Hoefner K eta/. Benign prostatic hyperplasia: a progressive disease of aging men. UrologY2003; 61: 267-73.
  • 3Lieber MM, Jacobsen S J, Roberts RO, Rhodes T, Girman CJ. Prostate volume and prostate-specific antigen in the absence of prostate cancer: a review of the relationship and prediction of long-term outcomes. Prostate 2001; 49: 208-12.
  • 4Marberger M J, Andersen JT, Nickel JC, Malice MP, Gabriel Met a/. Prostate volume and serum prostate-specific antigen as Combined experience from three large mu Uro/2000; 38: 563-8.
  • 5predictors of acute urinary retention. tinational placebo-controlled trials. Eur Pinsky PF, Kramer BS, Crawford ED, Grubb RL, Urban DA etaL Prostate volume and prostate-specific antigen levels in men enrolled in a large screening trial. Urology 2006; 68: 352-6.
  • 6Collins GN, Lee R J, McKelvie GB, Rogers AC, Hehir M. Relationship between prostate specific antigen, prostate volume and age in the benign prostate. BrJ Uro11993; 71: 445-50.
  • 7Mochtar CA, Kiemeney LA, van Riemsdijk MM, Barnett G$, Laguna MP etal. Prostate- specific antigen as an estimator of prostate volume in the management of patients with symptomatic benign prostatic hyperplasia. Eur Uro12003; 44: 695-700.
  • 8Hoohberg DA, Armenakas NA, Fracchia JA. Relationship of prostate-specific antigen and prostate volume in patients with biopsy proven benign prostatic hyperplasia. Prostate 2000; 45: 315-9.
  • 9Bosch JL, Hop WC, Bangma CH, Kirkels W J, Schroder FH. Prostate specific antigen in a community-based sample of men without prostate cancer: correlations with prostate volume, age, body mass index, and symptoms of prostatism. Prostate 1995; 27: 241- 9.
  • 10Bosch J L, Bohnen AM, Groeneveld FP. Validity of digital rectal examination and serum prostate specific antigen in the estimation of prostate volume in community-based men aged 50 to 78 years: the Krimpen Study. Eur Uro12004; 46: 753-9.

共引文献18

同被引文献59

引证文献6

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部